Advanced search
1 file | 1.84 MB

Alniditan, a new 5-hydroxytryptamine(1D) agonist and migraine-abortive agent: Ligand-binding properties of human 5-hydroxytryptamine(1D alpha), human 5-hydroxytryptamine(1D beta), and calf 5-hydroxytryptamine(1D) receptors investigated with [H-3]5-hydroxytryptamine and [H-3]Alniditan.

(1996) MOLECULAR PHARMACOLOGY. 50(6). p.1567-1580
Author
Organization

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.84 MB

Citation

Please use this url to cite or link to this publication:

Chicago
LEYSEN, JE, W GOMMEREN, L HEYLEN, WHML LUYTEN, I VANDEWEYER, Peter Vanhoenacker, Guy Haegeman, et al. 1996. “Alniditan, a New 5-hydroxytryptamine(1D) Agonist and Migraine-abortive Agent: Ligand-binding Properties of Human 5-hydroxytryptamine(1D Alpha), Human 5-hydroxytryptamine(1D Beta), and Calf 5-hydroxytryptamine(1D) Receptors Investigated with [H-3]5-hydroxytryptamine and [H-3]Alniditan.” Molecular Pharmacology 50 (6): 1567–1580.
APA
LEYSEN, J., GOMMEREN, W., HEYLEN, L., LUYTEN, W., VANDEWEYER, I., Vanhoenacker, P., Haegeman, G., et al. (1996). Alniditan, a new 5-hydroxytryptamine(1D) agonist and migraine-abortive agent: Ligand-binding properties of human 5-hydroxytryptamine(1D alpha), human 5-hydroxytryptamine(1D beta), and calf 5-hydroxytryptamine(1D) receptors investigated with [H-3]5-hydroxytryptamine and [H-3]Alniditan. MOLECULAR PHARMACOLOGY, 50(6), 1567–1580.
Vancouver
1.
LEYSEN J, GOMMEREN W, HEYLEN L, LUYTEN W, VANDEWEYER I, Vanhoenacker P, et al. Alniditan, a new 5-hydroxytryptamine(1D) agonist and migraine-abortive agent: Ligand-binding properties of human 5-hydroxytryptamine(1D alpha), human 5-hydroxytryptamine(1D beta), and calf 5-hydroxytryptamine(1D) receptors investigated with [H-3]5-hydroxytryptamine and [H-3]Alniditan. MOLECULAR PHARMACOLOGY. 1996;50(6):1567–80.
MLA
LEYSEN, JE, W GOMMEREN, L HEYLEN, et al. “Alniditan, a New 5-hydroxytryptamine(1D) Agonist and Migraine-abortive Agent: Ligand-binding Properties of Human 5-hydroxytryptamine(1D Alpha), Human 5-hydroxytryptamine(1D Beta), and Calf 5-hydroxytryptamine(1D) Receptors Investigated with [H-3]5-hydroxytryptamine and [H-3]Alniditan.” MOLECULAR PHARMACOLOGY 50.6 (1996): 1567–1580. Print.
@article{181271,
  author       = {LEYSEN, JE and GOMMEREN, W and HEYLEN, L and LUYTEN, WHML and VANDEWEYER, I and Vanhoenacker, Peter and Haegeman, Guy and SCHOTTE, A and VANGOMPEL, P and WOUTERS, R and LESAGE, AS},
  issn         = {0026-895X},
  journal      = {MOLECULAR PHARMACOLOGY},
  language     = {eng},
  number       = {6},
  pages        = {1567--1580},
  title        = {Alniditan, a new 5-hydroxytryptamine(1D) agonist and migraine-abortive agent: Ligand-binding properties of human 5-hydroxytryptamine(1D alpha), human 5-hydroxytryptamine(1D beta), and calf 5-hydroxytryptamine(1D) receptors investigated with [H-3]5-hydroxytryptamine and [H-3]Alniditan.},
  volume       = {50},
  year         = {1996},
}